ALMR

Alamar Biosciences makes instruments and lab supplies that detect disease markers in blood samples. Their NULISA technology can identify and measure proteins in a patient's blood that signal the presence of diseases like cancer, neurological disorders, and immune system problems. Research labs, pharmaceutical companies, and academic institutions use their equipment to study diseases and develop new treatments. The company also partners with organizations focused on Alzheimer's disease research.